Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
The Canadian Journal of Cardiology
|
October 1, 1995
Role of dietary fish protein in the regulation of plasma lipids
H Jacques, A Gascon, N Bergeron, et al.
British Journal of Urology
|
April 1, 1988
Benefits of combination therapy with flutamide in patients relapsing after castration
F Labrie, A Dupont, M Giguere, et al.
International Journal of Obesity (2005)
|
March 15, 2006
Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL
M-E Paradis, M-O Hogue, J-F Mauger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 16, 1999
Gender difference in postprandial lipemia : importance of visceral adipose tissue accumulation
C Couillard, N Bergeron, D Prud'homme, et al.
Diabetes
|
May 30, 1998
Postprandial triglyceride response in visceral obesity in men
C Couillard, N Bergeron, D Prud'homme, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 23, 1998
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase
N Bergeron, L Kotite, M Verges, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 3, 2001
Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations
C Couillard, N Bergeron, J Bergeron, et al.
European Journal of Clinical Nutrition
|
February 15, 2007
Kinetics of plasma apolipoprotein C-III as a determinant of diet-induced changes in plasma triglyceride levels
S Desroches, I L Ruel, Y Deshaies, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma
A Dupont, F Labrie, M Giguere, et al.
Journal of Steroid Biochemistry
|
October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer
F Labrie, A Dupont, L Cusan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
The Canadian Journal of Cardiology
|
October 1, 1995
Role of dietary fish protein in the regulation of plasma lipids
H Jacques, A Gascon, N Bergeron, et al.
British Journal of Urology
|
April 1, 1988
Benefits of combination therapy with flutamide in patients relapsing after castration
F Labrie, A Dupont, M Giguere, et al.
International Journal of Obesity (2005)
|
March 15, 2006
Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL
M-E Paradis, M-O Hogue, J-F Mauger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 16, 1999
Gender difference in postprandial lipemia : importance of visceral adipose tissue accumulation
C Couillard, N Bergeron, D Prud'homme, et al.
Diabetes
|
May 30, 1998
Postprandial triglyceride response in visceral obesity in men
C Couillard, N Bergeron, D Prud'homme, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 23, 1998
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase
N Bergeron, L Kotite, M Verges, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 3, 2001
Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations
C Couillard, N Bergeron, J Bergeron, et al.
European Journal of Clinical Nutrition
|
February 15, 2007
Kinetics of plasma apolipoprotein C-III as a determinant of diet-induced changes in plasma triglyceride levels
S Desroches, I L Ruel, Y Deshaies, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma
A Dupont, F Labrie, M Giguere, et al.
Journal of Steroid Biochemistry
|
October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer
F Labrie, A Dupont, L Cusan, et al.
Page
of 4